biosimilars

Deep Dive: Market Access – Breaking Barriers

https://pharmaphorum.com/views-analysis-market-access/deep-dive-market-access/

Merck & Co spin off could start a trend in big pharma

https://pharmaphorum.com/news/merck-cos-spin-off-closely-watched-by/

3 key trends shaping the immunology market

https://pharmaphorum.com/views-analysis-market-access/3-key-trends-shaping-the-immunology-market/

5 years of biosimilars in the US: what have we learned?

https://pharmaphorum.com/views-analysis-market-access/5-years-of-biosimilars-in-the-us-what-have-we-learned/

J+D Forecasting launches innovative pharmaceutical sales forecasting software

https://pharmaphorum.com/partner-content/jd-forecasting-launches-innovative-pharmaceutical-sales-forecasting-software/

Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US

https://pharmaphorum.com/news/pfizer-launches-biosimilars-to-roches-big-three-cancer-drugs-in-us/

New Dates Released for J+D’s Pharma Forecasting Training

https://pharmaphorum.com/partner-content/new-dates-released-for-jds-pharma-forecasting-training/

Nine pharma trends for 2020

https://pharmaphorum.com/views-analysis-digital/nine-pharma-trends-for-2020/

The 4 biggest pharma market access stories of 2019

https://pharmaphorum.com/views-analysis-market-access/the-4-biggest-pharma-market-access-stories-of-2019/

< 1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search